Search

everythinglearnresearchcommunity

for

Search:↓

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Skin symptoms can indicate endocrine disorders and have various treatments.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Skin-derived stem cells could help treat skin aging and pigmentation issues.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

ATP helps prevent skin damage from vandetanib by reducing stress.

Warfarin can rarely cause hair loss, which is usually reversible.

Homeopathic treatment improved symptoms and thyroid levels in a woman with subclinical hypothyroidism.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Hair changes can indicate systemic diseases or medication effects.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

MPA increases cancer spread by boosting Eph A2 activity.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.